Clinical Trials Browser

Phase 1 × dacomitinib × Tumor-Agnostic × Clear all

NCT00728390 2024-04-22

A Safety And Efficacy Study Of The Combination Of Oral PF-00299804 And Intravenous CP-751,871 Given Every 3 Weeks

Phase 1 Completed

Carcinoma, Neoplasm Metastasis

NCT00225121 2018-12-21

Study To Evaluate The Safety, Pharmacokinetics, And Pharmacodynamics Of PF-00299804 In Patients With Advanced Solid Tumors

Phase 1 Completed

Neoplasms

NCT00783328 2011-06-27

A Study Of PF-00299804 In Patients In Japan With Advanced Malignant Solid Tumors

Phase 1 Completed

Neoplasms